Alpha Sophia
Clinical Trials & RWD

Clinical Trials & Real-World Data

Clinical trials and real-world data (RWD/RWE) connect the evidence engine of life sciences to commercial execution. This collection covers identifying high-fit investigators and sites, accelerating patient and site recruitment with provider data, and using real-world evidence to support launches and HCP engagement. Learn how trial participation signals influence, and how RWD complements claims to build a fuller picture of provider behavior.

← Prev Next →

Frequently asked questions about Clinical Trials & RWD

What is real-world data (RWD) and real-world evidence (RWE)? +

RWD is data collected outside controlled trials — claims, EHRs, registries, and more. RWE is the clinical evidence derived from analyzing RWD. Together they show how treatments perform in everyday practice and how providers behave in the real world.

How does provider data speed up clinical trial recruitment? +

By targeting investigators and sites that already treat the relevant patient population — identified through procedure and diagnosis volumes — sponsors and CROs can prioritize high-enrollment sites and shorten startup timelines.

Why does trial participation matter for KOL identification? +

Investigators who participate in and publish from trials tend to shape peer practice. Tracking trial involvement alongside publications and procedure volume helps surface true clinical influencers earlier than legacy KOL lists.

← Back to all articles